Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.

Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

On a clear spring evening in Michigan, the stars aligned — just not in the way Upfront Ventures partner Nick Kim expected. He ...

Program serves as the organization's celebration of Women's History Month and year-round efforts to promote and foster female ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Trump's push follows in the footsteps of Reagan's Strategic Defense Initiative, a scrapped program popularly called "Star ...

The program started with 18 raised garden beds at Howell Park. Now, Baton Roots has expanded into public housing, classrooms, ...

The U.S. Air Force has dramatically plussed-up contracts with General Electric and Pratt & Whitney, both of which now have a ...

Pennsylvania’s emergency response system just got a major upgrade thanks to legislation passed last year to extend Next ...

ReliaQuest's Cyber Lab Bootcamp bridges the gap between education and real-world cybersecurity, tackling the talent shortage ...